case_images: PMC10282125_01
case_images: Pathological morphology examination.
case_images: fneur-14-1163990-g0001.jpg
case_images: PMC10282125_01_fneur-14-1163990-g0001.jpg
case_images: F1
case_images: Considering the results of the pathological morphology examination (Figure 1) comprehensively, she was diagnosed with endometrial carcinoma.
case_images: The pelvic MRI on 1 month after surgery showed no residual tumor tissue or metastasis.
case_images: fneur-14-1163990-g0002.jpg
case_images: PMC10282125_01_fneur-14-1163990-g0002.jpg
case_images: F2
case_images: The pelvic magnetic resonance imaging (Figure 2) at 1 month after surgery showed no residual tumor tissue, or metastasis was detected.
case_images: Ultrasonic testing showed venous blood flow in the lower extremities is smooth.
case_images: fneur-14-1163990-g0003.jpg
case_images: PMC10282125_01_fneur-14-1163990-g0003.jpg
case_images: F3
case_images: Neoplasm metastasis, recurrence, and deep venous thrombosis were excluded through a series of examinations like pelvic imaging and ultrasonic testing (Figure 3).
case_images: Medication adjustment and NRS scores along the timeline of disease. (A) Pregabalin 225 mg/day (75 mg 8 am, 150 mg 8 pm). (B) Pregabalin 150 mg/day (75 mg Q12 h). (C) Pregabalin 75 mg/day (75 mg 8 pm). (D) Stop medication intervention.
case_images: fneur-14-1163990-g0004.jpg
case_images: PMC10282125_01_fneur-14-1163990-g0004.jpg
case_images: F4
case_images: Subsequently, accompanied by acupuncture therapy and the improvement of pain, the dose of pregabalin was reduced gradually until it was discontinued (Figure 4).
case_images: PMC10282125_02